This study will evaluate the durability of antibody responses in children and adolescents after primary immunization with TBE vaccine
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
126
Blood draw only, no vaccine
Winkelhoferstr. 3
Ehingen, Germany
Fuggerplatz 1
Kaufering, Germany
Hauptstrasse 240
Kehl, Germany
Bismarckstr. 3
Ludwigsburg, Germany
Analysis of immunogenicity (TBE neutralizing antibody levels) 3 years after vaccination
Time frame: 3 years after vaccination
Analysis of immunogenicity (TBE neutralizing antibody levels) 4 years after vaccination
Time frame: 4 years after vaccination
Analysis of immunogenicity (TBE neutralizing antibody levels) 5 years after vaccination
Time frame: 5 years after vaccination
Analysis of immunogenicity (TBE antibody levels as measured by ELISA) at 3 years after vaccination
Time frame: 3 years after vaccination
Analysis of immunogenicity (TBE antibody levels as measured by ELISA) at 4 years after vaccination
Time frame: 4 years after vaccination
Analysis of immunogenicity (TBE antibody levels as measured by ELISA) at 5 years after vaccination
Time frame: 5 years after vaccination
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Am Marktplatz 8
Oberkirch, Germany
Großbottwarer Str. 47
Oberstenfeld, Germany
Wilhelmstr. 7
Offenburg, Germany
Stuttgarter Str. 74
Stuttgart, Germany
Martin-Niemöller-Str. 2
Traunreut, Germany
Murnauer Str. 3
Weilheim, Germany